- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04879238
Tailoring a Mindful Intervention to Enhance Opioid Treatment (BEING)
Tailoring a Mindful Intervention to Enhance Opioid Treatment Outcomes in a Community Program
Study Overview
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Connecticut
-
Hartford, Connecticut, United States, 06120
- Community Renewal Team
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Receiving Medication Assisted Treatment 18 years or older Released from incarceration within the past year Currently receiving services from the partnering community agency English speaking
Exclusion Criteria:
- Under 18 years old Non-English Speaking Current incarcerated Not receiving Medication Assisted Treatment Not receiving services from the partnering community agency
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Yoga-Mindfulness Intervention
Completing single session of yoga blended with mindfulness.
|
60 minute yoga session that blends mindfulness techniques
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Acceptability
Time Frame: 3 months following pre-test
|
Responses to questions about how acceptable participants found the intervention. The questions are indicated below: All questions can be responded to with one of the following answers: Completely disagree; disagree; neither agree nor disagree; agree; completely agree. I approve of the yoga and mindfulness training. I find the yoga and mindfulness training interesting. I like the yoga and mindfulness training. I welcome the yoga and mindfulness training. The training seems appropriate. The training applies to me. The training seems right for me. The training seems like a good match for me. The training seems easy to carry out. The training seems possible. The training seems doable. The training seems easy to use. |
3 months following pre-test
|
|
Adherence (self report)
Time Frame: 3 months following pre-test
|
Adherence to MAT per client self report-Response to question on whether they are still on MAT.
|
3 months following pre-test
|
|
Adherence (record review)
Time Frame: 3 months following intervention
|
Review of client chart to see if the client is still on MAT and taking as prescribed.
|
3 months following intervention
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Michael Fendrich, PhD, University of Connecticut
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- H20-0111
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.